Zhejiang Dayang Biotech Group Co (003017) — Cash Flow-to-Debt Ratio
Zhejiang Dayang Biotech Group Co (003017) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥638.25K could theoretically repay 0% of its total liabilities (CN¥650.82 Million) in one year. Check Zhejiang Dayang Biotech Group Co (003017) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Dayang Biotech Group Co Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Zhejiang Dayang Biotech Group Co across 13 annual periods. Also explore 003017 total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Zhejiang Dayang Biotech Group Co (2013–2025)
Year-by-year debt coverage analysis for Zhejiang Dayang Biotech Group Co. For market capitalisation and broader financial context, see 003017 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | CN¥160.11 Million | CN¥681.72 Million | ▲ +113.0% |
| 2024 | 0.11x | CN¥66.19 Million | CN¥600.40 Million | ▼ -67.5% |
| 2023 | 0.34x | CN¥182.42 Million | CN¥538.47 Million | ▲ +92.8% |
| 2022 | 0.18x | CN¥91.89 Million | CN¥522.92 Million | ▲ +291.7% |
| 2021 | -0.09x | CN¥-35.16 Million | CN¥383.64 Million | ▼ -122.1% |
| 2020 | 0.42x | CN¥112.49 Million | CN¥270.67 Million | ▼ -45.8% |
| 2019 | 0.77x | CN¥113.09 Million | CN¥147.51 Million | ▲ +218.3% |
| 2018 | 0.24x | CN¥38.77 Million | CN¥160.99 Million | ▼ -13.2% |
| 2017 | 0.28x | CN¥48.64 Million | CN¥175.37 Million | ▼ -22.2% |
| 2016 | 0.36x | CN¥84.63 Million | CN¥237.37 Million | ▲ +81.4% |
| 2015 | 0.20x | CN¥48.95 Million | CN¥249.12 Million | ▼ -9.3% |
| 2014 | 0.22x | CN¥57.73 Million | CN¥266.43 Million | ▼ -40.0% |
| 2013 | 0.36x | CN¥91.64 Million | CN¥253.93 Million | — |